What Researchers Did
Researchers reviewed 528 cases of altitude decompression sickness (DCS) treated with hyperbaric therapy between 1977 and 1986 to analyze exposure, diagnosis, treatment, and outcomes.
What They Found
The study found a significantly increased incidence of altitude DCS requiring hyperbaric therapy among females, with a relative risk 4.3 times that of males. It also confirmed the efficacy of hyperbaric oxygen therapy for altitude DCS. No significant difference in incidence rates was observed between duty positions in altitude chamber exposures.
What This Means for Canadian Patients
For Canadian patients experiencing altitude decompression sickness, hyperbaric oxygen therapy is an effective treatment option. Increased awareness of the higher risk among females could lead to earlier recognition and treatment.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
This retrospective review of cases from a specific period may limit the generalizability of its findings to current practices or broader populations.